Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Irritable Bowel Syndrome, May 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 51 articles:
HTML format


 

Single Articles

  1. ZHU X, Liu Z, Qin Y, Niu W, et al
    Analgesic effects of electroacupuncture at ST25 and CV12 in a rat model of postinflammatory irritable bowel syndrome visceral pain.
    Acupunct Med. 2018 May 2. pii: acupmed-2016-011320.
    Abstract    

    Abstract available

  2. JIA M, Lu X, Zhao L, Wang Z, et al
    Effects of Fengliao-Changweikang in Diarrhea-Predominant Irritable Bowel Syndrome Rats and its Mechanism Involving Colonic Motility.
    J Neurogastroenterol Motil. 2018 Apr 30. pii: jnm17093. doi: 10.5056/jnm17093.
    Abstract    

    Abstract available

  3. WANG HJ, Xu X, Xie RH, Rui YY, et al
    [EXPRESS] Prenatal maternal stress induces visceral hypersensitivity of adult rat offspring through activation of cystathionine-beta-synthase signaling in primary sensory neurons.
    Mol Pain. 2018 Jan 1:1744806918777406. doi: 10.1177/1744806918777406.
    Abstract    

    Abstract available

  4. KARAKULA-JUCHNOWICZ H, Galecka M, Rog J, Bartnicka A, et al
    The Food-Specific Serum IgG Reactivity in Major Depressive Disorder Patients, Irritable Bowel Syndrome Patients and Healthy Controls.
    Nutrients. 2018;10.
    Abstract    

    Abstract available

  5. CAMILLERI M
    Implications of Pharmacogenomics to the Management of IBS.
    Clin Gastroenterol Hepatol. 2018 Apr 27. pii: S1542-3565(18)30458.
    Abstract    

    Abstract available

  6. FODOR AA, Pimentel M, Chey WD, Lembo A, et al
    Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome.
    Gut Microbes. 2018 Apr 30:1-28. doi: 10.1080/19490976.2018.1460013.
    Abstract    

    Abstract available

  7. HILLEMACHER T, Bachmann O, Kahl KG, Frieling H, et al
    Alcohol, microbiome, and their effect on psychiatric disorders.
    Prog Neuropsychopharmacol Biol Psychiatry. 2018;85:105-115.
    Abstract    

    Abstract available

  8. HOLMES HJ, Thakur ER, Carty JN, Ziadni MS, et al
    Ambivalence over emotional expression and perceived social constraints as moderators of relaxation training and emotional awareness and expression training for irritable bowel syndrome.
    Gen Hosp Psychiatry. 2018;53:38-43.
    Abstract    

    Abstract available

  9. GARGARI G, Taverniti V, Gardana C, Cremon C, et al
    Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome.
    Environ Microbiol. 2018 May 11. doi: 10.1111/1462-2920.14271.
    Abstract    

    Abstract available

  10. MOHAJERI MH, Brummer RJM, Rastall RA, Weersma RK, et al
    The role of the microbiome for human health: from basic science to clinical applications.
    Eur J Nutr. 2018 May 10. pii: 10.1007/s00394-018-1703.
    Abstract    

    Abstract available

  11. FAN WJ, Zhang X, Fang XC
    [The immune factors in the pathogenesis of irritable bowel syndrome].
    Zhonghua Nei Ke Za Zhi. 2018;57:378-380.
    Abstract    



  12. JUEL J, Abrahamsen R, Olesen SS, Drewes AM, et al
    A pilot-study of hypnotherapy as complementary treatment for pain in chronic pancreatitis.
    J Complement Integr Med. 2018.
    Abstract    

    Abstract available

  13. ANDRESEN V, Miehlke S, Beck E, Wiseman G, et al
    Efficacy and tolerability of linaclotide in the treatment of irritable bowel syndrome with constipation in a realworld setting - results from a German noninterventional study.
    Z Gastroenterol. 2018 May 9. doi: 10.1055/s-0043-124875.
    Abstract    

    Abstract available

  14. KATSUMATA R, Ishii M, Lee S, Handa Y, et al
    Cytokine Profile and Immunoglobulin E-mediated Serological Food Hypersensitivity in Patients With Irritable Bowel Syndrome With Diarrhea.
    J Neurogastroenterol Motil. 2018 May 9. pii: jnm17114. doi: 10.5056/jnm17114.
    Abstract    

    Abstract available

  15. WEIR I, Shu Q, Wei N, Wei C, et al
    Efficacy of actinidin-containing kiwifruit extract Zyactinase on constipation: a randomised double-blinded placebo-controlled clinical trial.
    Asia Pac J Clin Nutr. 2018;27:564-571.
    Abstract    

    Abstract available

  16. BELCARO G, Gizzi G, Pellegrini L, Feragalli B, et al
    Pycnogenol(R) supplementation improves the control of irritable bowel syndrome symptoms.
    Panminerva Med. 2018;60:65-69.
    Abstract    

    Abstract available

  17. EVANGELISTA S, Traini C, Vannucchi MG
    Otilonium bromide: a drug with a complex mechanism of action.
    Curr Pharm Des. 2018 May 7. pii: CPD-EPUB-90224.
    Abstract    

    Abstract available

  18. YOO HY, Park B, Joo J, Kim JS, et al
    Validation of the Korean version of visual analogue scale for irritable bowel syndrome questionnaire for assessment of defecation pattern changes.
    Ann Surg Treat Res. 2018;94:254-261.
    Abstract    

    Abstract available

  19. MADISCH A, Miehlke S, Labenz J, Stracke B, et al
    Effectiveness of Menthacarin on symptoms of irritable bowel syndrome.
    Wien Med Wochenschr. 2018 May 4. pii: 10.1007/s10354-018-0635.
    Abstract    

    Abstract available

  20. TALLEY NJ, Holtmann G
    Irritable bowel syndrome and functional dyspepsia: what can epidemiology tell us about etiology?
    Expert Rev Gastroenterol Hepatol. 2018.
    Abstract    



  21. MATSUZAKI J, Suzuki H, Togawa K, Yamane T, et al
    Burden of impaired sleep quality on work productivity in functional dyspepsia.
    United European Gastroenterol J. 2018;6:398-406.
    Abstract    

    Abstract available

  22. LACY BE, Nicandro JP, Chuang E, Earnest DL, et al
    Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint.
    Therap Adv Gastroenterol. 2018;11:1756284818771674.
    Abstract    

    Abstract available

  23. EFFINGER A, O'Driscoll CM, McAllister M, Fotaki N, et al
    Impact of gastrointestinal disease states on oral drug absorption - implications for formulation design - a PEARRL review.
    J Pharm Pharmacol. 2018 May 16. doi: 10.1111/jphp.12928.
    Abstract    

    Abstract available

  24. TURCO R, Salvatore S, Miele E, Romano C, et al
    Does a low FODMAPs diet reduce symptoms of functional abdominal pain disorders? A systematic review in adult and paediatric population, on behalf of Italian Society of Pediatrics.
    Ital J Pediatr. 2018;44:53.
    Abstract    

    Abstract available

  25. DOLAN R, Chey WD, Eswaran S
    The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs.
    Expert Rev Gastroenterol Hepatol. 2018.
    Abstract    

    Abstract available

  26. POULSEN CH, Eplov LF, Hjorthoj C, Hastrup LH, et al
    Irritable bowel symptoms, use of healthcare, costs, sickness and disability pension benefits: A long-term population-based study.
    Scand J Public Health. 2018 May 1:1403494818776168.
    Abstract    

    Abstract available

  27. LATTANZIO SM, Imbesi F
    Fibromyalgia Syndrome: A Case Report on Controlled Remission of Symptoms by a Dietary Strategy.
    Front Med (Lausanne). 2018;5:94.
    Abstract    

    Abstract available

  28. GENG Q, Zhang QE, Wang F, Zheng W, et al
    Comparison of comorbid depression between irritable bowel syndrome and inflammatory bowel disease: A meta-analysis of comparative studies.
    J Affect Disord. 2018;237:37-46.
    Abstract    

    Abstract available

  29. GASKELL SK, Costa RJS
    Applying a Low-FODMAP Dietary Intervention to a Female Ultra-Endurance Runner With Irritable Bowel Syndrome During a Multi-Stage Ultra-Marathon.
    Int J Sport Nutr Exerc Metab. 2018 May 14:1-19. doi: 10.1123/ijsnem.2017-0398.
    Abstract    

    Abstract available

  30. DAGHAGHZADEH H, Memar A, Mohamadi Y, Rezakhani N, et al
    Therapeutic Effects of Low-dose Bismuth Subcitrate on Symptoms and Health-related Quality of Life in Adult Patients with Irritable Bowel Syndrome: A Clinical Trial.
    J Res Pharm Pract. 2018;7:13-21.
    Abstract    

    Abstract available

  31. TUNCALI B, Araz C, Celebi A
    Ambulatory colonoscopy under sedoanalgesia in adult patients with and without irritable bowel syndrome: A prospective, cross-sectional, and double-blind comparison.
    Turk J Gastroenterol. 2018;29:335-341.
    Abstract    

    Abstract available

  32. ZHAO JM, Lu JH, Yin XJ, Wu LY, et al
    Comparison of Electroacupuncture and Mild-Warm Moxibustion on Brain-Gut Function in Patients with Constipation-Predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Chin J Integr Med. 2018;24:328-335.
    Abstract    

    Abstract available

  33. BOSCH S, van Gaal N, Zuurbier RP, Covington JA, et al
    Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999303. doi: 10.1093.
    Abstract    

    Abstract available

  34. SEVOSTYANOVA EV, Nikolaev YA, Bogdankevich NV, Lusheva VG, et al
    [Combined rehabilitation in the patients presenting with dorsopathies of the lumbar spine and concomitant irritable bowel syndrome based at a therapeutic clinic].
    Vopr Kurortol Fizioter Lech Fiz Kult. 2018;95:10-18.
    Abstract    

    Abstract available

  35. PUSCEDDU MM, Murray K, Gareau MG
    Targeting the Microbiota, from Irritable Bowel Syndrome to Mood Disorders: Focus on Probiotics and Prebiotics.
    Curr Pathobiol Rep. 2018;6:1-13.
    Abstract    

    Abstract available

  36. MOHAMMADI EN, Ligon CO, Silos-Santiago A, Ge P, et al
    Linaclotide Attenuates Visceral Organ Crosstalk: Role of Guanylate Cyclase C Activation in Reversing Bladder-Colon Cross Sensitization.
    J Pharmacol Exp Ther. 2018 May 21. pii: jpet.118.248567.
    Abstract    

    Abstract available

  37. BYCHKOV MA, Ferents IM
    [Features of the course of irritable bowel syndrome in patients with excess body weight].
    Wiad Lek. 2018;71.
    Abstract    

    Abstract available

  38. SCHILLER LR
    Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0032.
    Abstract    

    Abstract available

  39. TESTA A, Imperatore N, Rispo A, Rea M, et al
    Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease.
    Dig Dis. 2018 May 15:1-10. doi: 10.1159/000489487.
    Abstract    

    Abstract available

  40. THAKUR ER, Shapiro J, Chan J, Lumley MA, et al
    A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study.
    Dig Dis Sci. 2018 May 10. pii: 10.1007/s10620-018-5095.
    Abstract    

    Abstract available

  41. ADKINS C, Rezaie A
    Small Intestinal Bacterial Overgrowth and Coronary Artery Disease: What Is in the CArDs?
    Dig Dis Sci. 2018;63:271-272.
    Abstract    



  42. MAHARSHAK N, Ringel Y, Katibian D, Lundqvist A, et al
    Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Dig Dis Sci. 2018 May 17. pii: 10.1007/s10620-018-5086.
    Abstract    

    Abstract available

  43. BORDEIANOU LG, Carmichael JC, Paquette IM, Wexner S, et al
    Consensus Statement of Definitions for Anorectal Physiology Testing and Pelvic Floor Terminology (Revised).
    Dis Colon Rectum. 2018;61:421-427.
    Abstract    



  44. WEGH CAM, Benninga MA, Tabbers MM
    Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review.
    J Clin Gastroenterol. 2018 May 18. doi: 10.1097/MCG.0000000000001054.
    Abstract    

    Abstract available

  45. CHEN B, Kim JJ, Zhang Y, Du L, et al
    Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis.
    J Gastroenterol. 2018 May 14. pii: 10.1007/s00535-018-1476.
    Abstract    

    Abstract available

  46. CHEN YJ, Wu H, Wu SD, Lu N, et al
    Parasutterella, in associated with Irritable Bowel Syndrome and intestinal chronic inflammation.
    J Gastroenterol Hepatol. 2018 May 9. doi: 10.1111/jgh.14281.
    Abstract    

    Abstract available

  47. PAWLOWSKA K, Umlawska W, Iwanczak B
    A Link between Nutritional and Growth States in Pediatric Patients with Functional Gastrointestinal Disorders.
    J Pediatr. 2018 Apr 27. pii: S0022-3476(18)30324.
    Abstract    

    Abstract available

  48. CHUMPITAZI BP, Lim J, McMeans AR, Shulman RJ, et al
    Evaluation of FODMAP Carbohydrates Content in Selected Foods in the United States.
    J Pediatr. 2018 Apr 26. pii: S0022-3476(18)30385.
    Abstract    

    Abstract available

  49. SANTUCCI NR, Hyman PE
    Do Functional Gastrointestinal Disorders Affect Growth and Nutrition?
    J Pediatr. 2018 May 3. pii: S0022-3476(18)30495.
    Abstract    



  50. LIU X, Liu K
    Association of irritable bowel syndrome and venous thromboembolism: methodological and statistical issues.
    Scand J Gastroenterol. 2018 May 20:1. doi: 10.1080/00365521.2018.1473487.
    Abstract    



  51. D'ERRICO F, Goverse G, Dai Y, Wu W, et al
    Estrogen receptor beta controls proliferation of enteric glia and differentiation of neurons in the myenteric plexus after damage.
    Proc Natl Acad Sci U S A. 2018 May 14. pii: 1720267115.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;